PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 83 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,033,000 | +176.2% | 96,000 | +2894.4% | 0.15% | +166.1% |
| Q2 2015 | $374,000 | -53.9% | 3,206 | -6.8% | 0.06% | -50.9% |
| Q1 2015 | $812,000 | +83.7% | 3,441 | +47.3% | 0.11% | +78.1% |
| Q4 2014 | $442,000 | -20.6% | 2,336 | 0.0% | 0.06% | -24.7% |
| Q3 2014 | $557,000 | +76.8% | 2,336 | -51.0% | 0.08% | +84.8% |
| Q2 2014 | $315,000 | -32.1% | 4,770 | +7.0% | 0.05% | -32.4% |
| Q1 2014 | $464,000 | -88.0% | 4,459 | -88.1% | 0.07% | -87.6% |
| Q4 2013 | $3,869,000 | +1132.2% | 37,367 | +538.0% | 0.55% | +1039.6% |
| Q3 2013 | $314,000 | +26.6% | 5,857 | +4.7% | 0.05% | +9.1% |
| Q2 2013 | $248,000 | – | 5,596 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |